![]() |
![]() |
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 36.46 | ACUITE C | Reaffirmed & Withdrawn | - |
Bank Loan Ratings | 6.36 | Not Applicable | Withdrawn | - |
Total Outstanding | 0.00 | - | - |
Total Withdrawn | 42.82 | - | - |
Rating Rationale |
Acuite has reaffirmed and withdrawn its long-term rating of ‘ACUITE C' (read as ACUITE C) on the Rs. 36.46 crore bank facilities of Mahika Packaging India Limited (MPIL). The rating is being withdrawn on account of request received from the company and NOC (No Objection Certificate) received from the banker. |
About the Company |
Incorporated in 2005, Mumbai based Mahika Packaging India Limited (MPIL) is engaged in manufacturing of custom plastic packaging solutions across different market sectors including personal care, healthcare, chemical and household product markets Mahika Packaging India Limited current product portfolio includes dispensing caps and closures, plastic bottles, co-extruded tubes, laminated tubes, self-adhesive labels and shrink sleeves that are designed to cater to specific needs and demands of different industries. Mahika Packaging India Limited has its manufacturing facilities are located in Daman and Vapi the company has its presence in domestic as well as international markets such as Australia, the U.S.A, the Middle East, South Africa, and Turkey to name a few. The current director of company is Mr. Amit Sushil Gupta, Mr. Tapan Kumar Banerjee, Mrs. Gunjan Parun Mehra, Mr. Sushil Brijlal Gupta and Mr. Sumit Sushil Gupta.
|
Unsupported Rating |
Not Applicable
|
Analytical Approach |
Acuité has considered the standalone view of the business and financial risk profile of MPIL to arrive at the rating.
|
Key Rating Drivers |
Strengths |
Experienced Management with established track record of operations
The promoter, Mr. Sushil Gupta has an extensive experience in the packaging industry for more than two decades. The other members of the family including his two sons Mr. Amit Gupta and Mr. Sunil Gupta are also engaged in the business. The extensive experience of the promoters and established presence in the industry has helped the company to generate healthy relations with various customers and suppliers in the domestic market as well as international market. MPIL caters to a reputed client base including Dabur India, Castrol India, Unilever, Patanjali Ayurved, Torrent Pharmaceuticals, Ipca Laboratories, Abbott Laboratories in India to name a few. In the international market, the company has its presence in Australia, the USA, the Middle East, South Africa, and Turkey to name a few. Its portfolio of international clients consists of Walmart, Walgreens, CVS Pharmacy to name a few. Moderate financial risk profile MPIL has a moderate financial risk profile marked by moderate net worth, moderate gearing and moderate debt protection metrics. MPIL’s net worth stood marginally improved to Rs. 59.92 crore as of March 31, 2024 against Rs. 53.03 crore as of March 31, 2023, on account of accretion of profits to reserves. The company’s gearing stood marginally improved at 0.67 times as on March 31,2024 as against 0.82 times as on March 31, 2023, on account of decrease in the long term debt availed by the company. The company’s total debt as on March 31,2024 stood at Rs. 40.35 crore as compared to Rs. 43.54 crore as on March 31, 2023; comprising of long-term debt of Rs. 10.24 crore, short-term debt of Rs. 19.53 crore and maturing debt obligation of Rs. 10.58 crore. The interest coverage ratio of the company stood at 3.96 times in FY24 against 2.99 times in FY23. DSCR stood at 1.56 times in FY2024 against 3.34 times in FY2023. |
Weaknesses |
Instances of delays in servicing of debt obligations Moderate operating performance albeit decline in revenues |
Rating Sensitivities |
Not Applicable
|
Liquidity Position |
Poor |
The company’s liquidity position is poor marked by recent instances of delays in meeting repayment obligations as reflected in the credit information bureau report. |
Outlook: Not Applicable |
|
Other Factors affecting Rating |
None
|
Particulars | Unit | FY 24 (Actual) | FY 23 (Actual) |
Operating Income | Rs. Cr. | 83.08 | 121.97 |
PAT | Rs. Cr. | 6.07 | 9.36 |
PAT Margin | (%) | 7.31 | 7.67 |
Total Debt/Tangible Net Worth | Times | 0.67 | 0.82 |
PBDIT/Interest | Times | 3.96 | 2.99 |
Status of non-cooperation with previous CRA (if applicable) |
Not Applicable
|
Any other information |
None
|
Applicable Criteria |
• Default Recognition :- https://www.acuite.in/view-rating-criteria-52.htm • Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
Note on complexity levels of the rated instrument |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Contacts |
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |